Bugaj JE - Search Results

1

Synthesis, in vitro receptor binding, and in vivo evaluation of fluorescein and carbocyanine peptide-based optical contrast agents.

Achilefu S, Jimenez HN, Dorshow RB, Bugaj JE, Webb EG, Wilhelm RR, Rajagopalan R, Johler J, Erion JL. Achilefu S, et al. Among authors: bugaj je. J Med Chem. 2002 May 9;45(10):2003-15. doi: 10.1021/jm010519l. J Med Chem. 2002. PMID: 11985468

2

Novel bioactive and stable neurotensin peptide analogues capable of delivering radiopharmaceuticals and molecular beacons to tumors.

Achilefu S, Srinivasan A, Schmidt MA, Jimenez HN, Bugaj JE, Erion JL. Achilefu S, et al. Among authors: bugaj je. J Med Chem. 2003 Jul 17;46(15):3403-11. doi: 10.1021/jm030081k. J Med Chem. 2003. PMID: 12852770

3

Novel fluorescent contrast agents for optical imaging of in vivo tumors based on a receptor-targeted dye-peptide conjugate platform.

Bugaj JE, Achilefu S, Dorshow RB, Rajagopalan R. Bugaj JE, et al. J Biomed Opt. 2001 Apr;6(2):122-33. doi: 10.1117/1.1352748. J Biomed Opt. 2001. PMID: 11375721 Free article.

4

DOTA-D-Tyr(1)-octreotate: a somatostatin analogue for labeling with metal and halogen radionuclides for cancer imaging and therapy.

Li WP, Lewis JS, Kim J, Bugaj JE, Johnson MA, Erion JL, Anderson CJ. Li WP, et al. Among authors: bugaj je. Bioconjug Chem. 2002 Jul-Aug;13(4):721-8. doi: 10.1021/bc015590k. Bioconjug Chem. 2002. PMID: 12121126

5

Stabilization of the optical tracer agent indocyanine green using noncovalent interactions.

Rajagopalan R, Uetrecht P, Bugaj JE, Achilefu SA, Dorshow RB. Rajagopalan R, et al. Among authors: bugaj je. Photochem Photobiol. 2000 Mar;71(3):347-50. doi: 10.1562/0031-8655(2000)071<0347:sotota>2.0.co;2. Photochem Photobiol. 2000. PMID: 10732454

6

Novel receptor-targeted fluorescent contrast agents for in vivo tumor imaging.

Achilefu S, Dorshow RB, Bugaj JE, Rajagopalan R. Achilefu S, et al. Among authors: bugaj je. Invest Radiol. 2000 Aug;35(8):479-85. doi: 10.1097/00004424-200008000-00004. Invest Radiol. 2000. PMID: 10946975

7

Preparation, characterization, and biological evaluation of technetium(V) and rhenium(V) complexes of novel heterocyclic tetradentate N3S ligands.

Rajagopalan R, Grummon GD, Bugaj J, Hallemann LS, Webb EG, Marmion ME, Vanderheyden JL, Srinivasan A. Rajagopalan R, et al. Bioconjug Chem. 1997 May-Jun;8(3):407-15. doi: 10.1021/bc9700401. Bioconjug Chem. 1997. PMID: 9177848

8

Radiotherapeutic efficacy of (153)Sm-CMDTPA-Tyr(3)-octreotate in tumor-bearing rats.

Bugaj JE, Erion JL, Johnson MA, Schmidt MA, Srinivasan A. Bugaj JE, et al. Nucl Med Biol. 2001 Apr;28(3):327-34. doi: 10.1016/s0969-8051(01)00197-4. Nucl Med Biol. 2001. PMID: 11323245

9

Next tier in vitro and in vivo nonclinical studies further elucidating the safety and toxicity profile of MB-102, a novel fluorescent tracer agent for measurement of glomerular filtration rate.

Dorshow RB, Bugaj JE. Dorshow RB, et al. Among authors: bugaj je. Regul Toxicol Pharmacol. 2019 Oct;107:104417. doi: 10.1016/j.yrtph.2019.104417. Epub 2019 Jul 2. Regul Toxicol Pharmacol. 2019. PMID: 31276731

10

Evaluation of Developmental and Reproductive Toxicity in Rabbits for MB-102, a Fluorescent Tracer Agent Designed for Real-Time Measurement of Glomerular Filtration Rate.

Bugaj JE, Dorshow RB. Bugaj JE, et al. Int J Toxicol. 2022 Sep-Oct;41(5):380-388. doi: 10.1177/10915818221111331. Epub 2022 Jun 27. Int J Toxicol. 2022. PMID: 35758830

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters